Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: France Clear all

102 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20031
20046
20054
20065
20075
20082
20092
20105
20114
20125
20139
20149
20152
20165
20171
20184
20193
20201
20216
20225
20234
20244
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed63
Recruiting13
Terminated10
Active, not recruiting8
Unknown status6
No longer available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals28
Bristol-Myers Squibb10
Poitiers University Hospital9
University Hospital, Bordeaux6
Hospices Civils de Lyon4
Pfizer4
Teva Branded Pharmaceutical Products R&D, Inc.3
University Hospital, Clermont-Ferrand3
Versailles Hospital3
Ariad Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive102
Leukemia14
Precursor Cell Lymphoblastic Leukemia-Lymphoma13
Bronchiolitis Obliterans Syndrome7
Leukemia, Myeloid, Acute7
Leukemia, Myeloid, Chronic-Phase7
Philadelphia Chromosome7
Hematologic Diseases6
Leukemia, Myeloid6
Blast Crisis5

Trials

Showing 26 to 50 of 102. Each trial links to its page on Pharma Observatory.

2 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.